Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $20.3150 (5.12%) ($20.3150 - $20.3150) on Fri. Feb. 5, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4% (three month average) | RSI | 63 | Latest Price | $20.3150(5.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2% a day on average for past five trading days. | Weekly Trend | ATRA advances 2.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -2% in a week (0% probabilities). VIXM(-35%) VXX(-27%) UNG(-10%) UUP(-9%) TLT(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2% (StdDev 4%) | Hourly BBV | 2.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $19.43(4.55%) | 10 Day Moving Average | $19.24(5.59%) | 20 Day Moving Average | $19.13(6.19%) | To recent high | -22.8% | To recent low | 51.1% | Market Cap | $1.51b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |